US Patent 10363269 Modified hepatitis post-transcriptional regulatory elements
Patent 10363269 was granted and assigned to Juno Therapeutics on July, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10363269 Modified hepatitis post-transcriptional regulatory elements
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
